Fair comment. However there will come a time when a line needs to be drawn. Nothing alters the fact that a massive amount of capital is required to develop a vaccine / drug.Building a stake in Admedus vaccines is not a positive if it doesn't succeed. We are just financing research.
My belief is the company would thrive without the vaccine.
Previously I have suggested creating a separate company listing for the vaccine. This allows investors to decide whether they want to finance research ,or support a growing company. They also have the opportunity to do both.
- Forums
- ASX - By Stock
- any reason for share price wilting?
Fair comment. However there will come a time when a line needs...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.00 |
Change
-0.150(0.99%) |
Mkt cap ! $317.0M |
Open | High | Low | Value | Volume |
$15.00 | $15.10 | $14.85 | $133.6K | 8.912K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $14.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 510 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 327 | 14.850 |
2 | 1350 | 14.750 |
2 | 399 | 14.600 |
1 | 30 | 14.500 |
1 | 60 | 14.400 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 510 | 1 |
15.140 | 150 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |